Thursday, December 22, 2011

Intravenous Administration Of THC Not Associated With 'Serious Adverse Events' In Human Subjects

Intravenous Administration Of THC Not Associated With 'Serious Adverse Events' In Human Subjects: "Thursday, 25 August 2011

West Haven, CT: The intravenous administration of cannabis' primary psychoactive compound, delta-9-THC, poses a "relatively low" risk to subjects' health, according to a review of clinical trial data to be published in the journal Psychopharmacology.

A team of investigators at the West Haven, Connecticut branch of the US Department of Veteran Affairs conducted a review of all intravenous THC studies conducted at the center over a 13-year period. They assessed 11 studies involving 266 subjects (14 schizophrenia patients and 252 healthy subjects, of whom 76 were frequent cannabis users), 351 active THC infusions, and 226 placebo infusions. Study subjects were monitored for subjective and physical adverse events and followed up to 12months beyond study participation."

'via Blog this'

No comments:

Post a Comment